Literature DB >> 29465651

The Epidemiology of Syphilis in New York City: Historic Trends and the Current Outbreak Among Men Who Have Sex With Men, 2016.

Julia Ann Schillinger, Jennifer Sanderson Slutsker1, Preeti Pathela1, Ellen J Klingler1, Robin R Hennessy, Brian Toro1, Susan Blank.   

Abstract

BACKGROUND: Male primary and secondary (P&S) and early latent syphilis cases have increased markedly in New York City (NYC) after a historic nadir in 1998. The majority of cases are among men who have sex with men (MSM). We describe the epidemiology of syphilis among NYC males to provide a model of how 1 jurisdiction collects, analyzes, interprets, uses, and disseminates local data to guide programmatic activities directed at syphilis control.
METHODS: We analyzed trends in reported infectious syphilis cases using routinely collected surveillance and case investigation data. Human immunodeficiency virus (HIV) coinfection status was ascertained by routine deterministic match between sexually transmitted infection and HIV surveillance registries, and self-report. We mapped diagnosing facilities to display the relative contribution of different public/private facilities. Characteristics of male syphilis cases diagnosed in public sexual health (SH) clinics were compared to those diagnosed elsewhere.
RESULTS: During 2012 to 2016, male P&S syphilis case rates increased 81%, from 24.8 to 44.8/100,000 (1832 cases in 2016); the highest rates were among black non-Hispanic men. Overall, 87.6% (902/1030) of interviewed men in 2016 disclosed 1 or more male partner. The HIV coinfection rates are high among MSM with P&S syphilis (43.4%; 394/907 in 2016), but appear to be decreasing (from 54.1% in 2012). Maps highlight SH clinics' contribution to diagnosing P&S syphilis cases among men of color. HIV coinfection rates were lower among men with P&S syphilis diagnosed in SH clinics than among those diagnosed elsewhere (34%, SH clinics vs 49%; other settings, P < 0.0001).
CONCLUSIONS: Syphilis infections continue to increase among MSM in NYC. Novel interventions responsive to the drivers of the current outbreak are needed.

Entities:  

Mesh:

Year:  2018        PMID: 29465651     DOI: 10.1097/OLQ.0000000000000796

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  6 in total

1.  An Educational Intervention to Improve Provider Screening for Syphilis Among Men Who Have Sex with Men Utilizing an Urban Urgent Care Center.

Authors:  Dina Romo; Gowri Nagendra; Sarah Schechter; April Pavlish; Alwyn Cohall; Natalie Neu
Journal:  J Community Health       Date:  2019-08

2.  Immunological Changes in Monocyte Subsets and Their Association With Foxp3+ Regulatory T Cells in HIV-1-Infected Individuals With Syphilis: A Brief Research Report.

Authors:  Na Guo; Lifeng Liu; Xiaodong Yang; Ting Song; Guanxin Li; Li Li; Taiyi Jiang; Yanqing Gao; Tong Zhang; Bin Su; Hao Wu
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

3.  Enhancing the Control of Syphilis Among Men Who Have Sex With Men by Focusing on Acute Infectious Primary Syphilis and Core Transmission Groups.

Authors:  Robert A Gunn; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2019-10       Impact factor: 2.830

4.  Meningovascular Syphilis Presenting as a Brain Mass in an Immunocompetent Male.

Authors:  Khanh Pham; Lee Gottesdiener; Matthew S Simon; Alex Trzebucki; Grace A Maldarelli; Babacar Cisse; Joshua Lieberman; Elliot DeHaan; David Pisapia
Journal:  Open Forum Infect Dis       Date:  2021-08-31       Impact factor: 3.835

5.  Oral Manifestations of Early Syphilis in Adults: A Systematic Review of Case Reports and Series.

Authors:  Xiao Zhou; Min-Zhi Wu; Ting-Ting Jiang; Xiang-Sheng Chen
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

6.  Factors Contributing to Congenital Syphilis Cases - New York City, 2010-2016.

Authors:  Jennifer Sanderson Slutsker; Robin R Hennessy; Julia A Schillinger
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-10-05       Impact factor: 17.586

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.